Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Other Non-Current Assets: 2021-2024

Historic Other Non-Current Assets for Kiniksa Pharmaceuticals International (KNSA) over the last 4 years, with Dec 2024 value amounting to $10.3 million.

  • Kiniksa Pharmaceuticals International's Other Non-Current Assets rose 5.54% to $8.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year increase of 5.54%. This contributed to the annual value of $10.3 million for FY2024, which is 1147.28% up from last year.
  • Latest data reveals that Kiniksa Pharmaceuticals International reported Other Non-Current Assets of $10.3 million as of FY2024, which was up 1,147.28% from $827,000 recorded in FY2023.
  • Kiniksa Pharmaceuticals International's Other Non-Current Assets' 5-year high stood at $10.3 million during FY2024, with a 5-year trough of $827,000 in FY2023.
  • In the last 3 years, Kiniksa Pharmaceuticals International's Other Non-Current Assets had a median value of $5.8 million in 2022 and averaged $5.7 million.
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's Other Non-Current Assets tumbled by 85.80% in 2023 and then soared by 1,147.28% in 2024.
  • Kiniksa Pharmaceuticals International's Other Non-Current Assets (MRY) stood at $8.7 million in 2021, then tumbled by 33.21% to $5.8 million in 2022, then tumbled by 85.80% to $827,000 in 2023, then soared by 1,147.28% to $10.3 million in 2024.
  • Its Other Non-Current Assets stands at $10.3 million for FY2024, versus $827,000 for FY2023 and $5.8 million for FY2022.